litlas
ログインアカウント作成

Michael A. Caligiuri

1987–2026 年に発表

257
論文数
63,832
被引用数
134
h 指数
251
i10 指数

被引用数

Michael A. Caligiuri の年別被引用数1984 年: 被引用 1 件1988 年: 被引用 6 件1989 年: 被引用 7 件1990 年: 被引用 20 件1991 年: 被引用 38 件1992 年: 被引用 33 件1993 年: 被引用 35 件1994 年: 被引用 34 件1995 年: 被引用 44 件1996 年: 被引用 51 件1997 年: 被引用 55 件1998 年: 被引用 88 件1999 年: 被引用 93 件2000 年: 被引用 105 件2001 年: 被引用 205 件2002 年: 被引用 287 件2003 年: 被引用 321 件2004 年: 被引用 442 件2005 年: 被引用 520 件2006 年: 被引用 460 件2007 年: 被引用 555 件2008 年: 被引用 645 件2009 年: 被引用 581 件2010 年: 被引用 712 件2011 年: 被引用 720 件2012 年: 被引用 708 件2013 年: 被引用 749 件2014 年: 被引用 851 件2015 年: 被引用 762 件2016 年: 被引用 777 件2017 年: 被引用 763 件2018 年: 被引用 675 件2019 年: 被引用 2,151 件2020 年: 被引用 2,241 件2021 年: 被引用 2,309 件2022 年: 被引用 1,798 件2023 年: 被引用 1,177 件2024 年: 被引用 1,918 件2025 年: 被引用 979 件2026 年: 被引用 23 件1985〜1987 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 7,580 件、この内訳の 31%中国: 引用元論文 3,187 件、この内訳の 13%ドイツ: 引用元論文 1,548 件、この内訳の 6.3%イタリア: 引用元論文 1,246 件、この内訳の 5.1%イギリス: 引用元論文 1,196 件、この内訳の 4.9%フランス: 引用元論文 957 件、この内訳の 3.9%カナダ: 引用元論文 782 件、この内訳の 3.2%日本: 引用元論文 661 件、この内訳の 2.7%オーストラリア: 引用元論文 572 件、この内訳の 2.4%スペイン: 引用元論文 545 件、この内訳の 2.2%オランダ: 引用元論文 540 件、この内訳の 2.2%スウェーデン: 引用元論文 364 件、この内訳の 1.5%
0%31%その他 21.6%

機関

分野

  • Medicine39.8%
  • Immunology and Microbiology29.5%
  • Biochemistry, Genetics and Molecular Biology26.9%
  • Neuroscience1.4%
  • Engineering0.6%
  • Agricultural and Biological Sciences0.4%
  • その他1.4%

トピック

  • Immune Cell Function and Interaction10.6%
  • CAR-T cell therapy research4.4%
  • T-cell and B-cell Immunology4.3%
  • Acute Myeloid Leukemia Research3.5%
  • MicroRNA in disease regulation2.8%
  • Immunotherapy and Immune Responses2.5%
  • その他71.9%

共著者

全論文

検索で開く
  1. Innate or Adaptive Immunity? The Example of Natural Killer Cells

    著者: Éric Vivier, David H. Raulet, Alessandro Moretta, Michael A. Caligiuri, Laurence Zitvogel, Lewis L. Lanier, Wayne M. Yokoyama, Sophie Ugolini - Science 2011 被引用: 2,757

  2. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

    著者: Tsvee Lapidot, Christian Sirard, Josef Vormoor, Barbara Murdoch, Trang Hoang, Julio Roberto Cáceres‐Cortés, Mark D. Minden, Bruce M. Paterson, Michael A. Caligiuri, John E. Dick - Nature 1994 被引用: 4,743

  3. The biology of human natural killer-cell subsets

    著者: Megan A. Cooper, Todd A. Fehniger, Michael A. Caligiuri - Trends in Immunology 2001 被引用: 2,928

  4. The emerging field of oncolytic virus-based cancer immunotherapy

    著者: Rui Ma, Zhenlong Li, E. Antonio Chiocca, Michael A. Caligiuri, Jianhua Yu - Trends in cancer 2022 被引用: 288

  5. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells

    著者: Shoubao Ma, Baofa Sun, Songqi Duan, Jingjing Han, Tasha Barr, Jianying Zhang, Marc B. Bissonnette, Marcin Kortylewski, Chuan He, Jianjun Chen, Michael A. Caligiuri, Jianhua Yu - Nature Immunology 2023 被引用: 219

  6. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response

    著者: Muller Fabbri, Alessio Paone, Federica Calore, Roberta Galli, Eugenio Gaudio, Ramasamy Santhanam, Francesca Lovat, Paolo Fadda, Charlene Mao, Gerard J. Nuovo, Nicola Zanesi, Melissa Crawford, Gülçin Özer, Dorothee Wernicke, Hansjüerg Alder, Michael A. Caligiuri, Patrick Nana‐Sinkam, Danilo Perrotti, Carlo M. Croce - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 被引用: 1,543

  7. Obesity, Inflammation, and Cancer

    著者: Tuo Deng, Christopher J. Lyon, Stephen M. Bergin, Michael A. Caligiuri, Willa A. Hsueh - Annual Review of Pathology Mechanisms of Disease 2016 被引用: 807

  8. Human natural killer cells

    著者: Michael A. Caligiuri - Blood 2008 被引用: 1,893

  9. The Broad Spectrum of Human Natural Killer Cell Diversity

    著者: Aharon G. Freud, Bethany L. Mundy-Bosse, Jianhua Yu, Michael A. Caligiuri - Immunity 2017 被引用: 690

  10. An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma

    著者: Rui Ma, Ting Lu, Zhenlong Li, Kun‐Yu Teng, Anthony G. Mansour, Melissa Yu, Lei Tian, Bo Xu, Shoubao Ma, Jianying Zhang, Tasha Barr, Yong Peng, Michael A. Caligiuri, Jianhua Yu - Cancer Research 2021 被引用: 214

  11. Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy

    著者: Shoubao Ma, Michael A. Caligiuri, Jianhua Yu - Trends in Immunology 2022 被引用: 214

  12. Off-the-Shelf Prostate Stem Cell Antigen–Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer

    著者: Kun‐Yu Teng, Anthony G. Mansour, Zheng Zhu, Zhiyao Li, Lei Tian, Shoubao Ma, Bo Xu, Ting Lu, Hanyu Chen, David Hou, Jianying Zhang, Saul J. Priceman, Michael A. Caligiuri, Jianhua Yu - Gastroenterology 2022 被引用: 126

  13. Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion

    著者: Anna Paczulla, Kathrin Rothfelder, Simon Raffel, Martina Konantz, Julia Steinbacher, Hui Wang, Claudia Tandler, Marcelle Ndoh Mbarga, Thorsten Schaefer, Mattia Falcone, Eva Nievergall, Daniela Dörfel, Pauline Hanns, Jakob Passweg, Christoph Lutz, Juerg Schwaller, Robert Zeiser, Bruce R. Blazar, Michael A. Caligiuri, Stephan Dirnhofer, Pontus Lundberg, Lothar Kanz, Leticia Quintanilla‐Martínez, Alexander Steinle, Andreas Trumpp, Helmut R. Salih, Claudia Lengerke - Nature 2019 被引用: 393

  14. Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset

    著者: Megan A. Cooper, Todd A. Fehniger, Sarah C. Turner, Kenneth Chen, Bobak A. Ghaheri, Tariq Ghayur, William E. Carson, Michael A. Caligiuri - Blood 2001 被引用: 1,426

  15. The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity

    著者: Shoubao Ma, Jiazhuo Yan, Tasha Barr, Jianying Zhang, Zhenhua Chen, Li‐Shu Wang, Joseph C. Sun, Jianjun Chen, Michael A. Caligiuri, Jianhua Yu - The Journal of Experimental Medicine 2021 被引用: 207

  16. The Mechanism of Anti–PD-L1 Antibody Efficacy against PD-L1–Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector

    著者: Wenjuan Dong, Xiaojin Wu, Shoubao Ma, Yufeng Wang, Ansel P. Nalin, Zheng Zhu, Jianying Zhang, Don M. Benson, Kai He, Michael A. Caligiuri, Jianhua Yu - Cancer Discovery 2019 被引用: 307

  17. Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer

    著者: Zahir Shah, Lei Tian, Zhixin Li, Lewei Jin, Jianying Zhang, Zhenlong Li, Tasha Barr, Hejun Tang, Mingye Feng, Michael A. Caligiuri, Jianhua Yu - Cell stem cell 2024 被引用: 77

  18. Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function

    著者: Andrew Stiff, Prashant Trikha, Bethany L. Mundy-Bosse, Elizabeth L. McMichael, Thomas A. Mace, Brooke Benner, Kari Kendra, Amanda R. Campbell, Shalini Gautam, David Abood, Ian Landi, Vincent Hsu, Megan Duggan, Robert Wesolowski, Matthew Old, John H. Howard, Lianbo Yu, Nancy Stasik, Thomas Olencki, Natarajan Muthusamy, Susheela Tridandapani, John C. Byrd, Michael A. Caligiuri, William E. Carson - Clinical Cancer Research 2018 被引用: 236

  19. Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes

    著者: Jason A. Dubovsky, Kyle A. Beckwith, Gayathri Natarajan, Jennifer A. Woyach, Samantha Jaglowski, Yiming Zhong, Joshua Hessler, Ta-Ming Liu, Betty Chang, Karilyn M. Larkin, Matthew Stefanovski, Danielle L. Chappell, Frank Frissora, Lisa L. Smith, Kelly A. Smucker, Joseph M. Flynn, Jeffrey A. Jones, Leslie A. Andritsos, Kami J. Maddocks, Amy M. Lehman, Richard R. Furman, Jeff P. Sharman, Anjali Mishra, Michael A. Caligiuri, Abhay R. Satoskar, Joseph J. Buggy, Natarajan Muthusamy, Amy J. Johnson, John C. Byrd - Blood 2013 被引用: 796

  20. Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity

    著者: Lei Tian, Bo Xu, Yuqing Chen, Zhenlong Li, Jing Wang, Jianying Zhang, Rui Ma, Shuai Cao, Weidong Hu, E. Antonio Chiocca, Balveen Kaur, Michael A. Caligiuri, Jianhua Yu - Nature Cancer 2022 被引用: 79

  21. The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody

    著者: Don M. Benson, Courtney E. Bakan, Anjali Mishra, Craig C. Hofmeister, Yvonne A. Efebera, Brian Becknell, Robert A. Baiocchi, Jianying Zhang, Jianhua Yu, Megan Smith, Carli N Greenfield, Pierluigi Porcu, Steven M. Devine, Rinat Rotem‐Yehudar, Gerard Lozanski, John C. Byrd, Michael A. Caligiuri - Blood 2010 被引用: 801

  22. Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy

    著者: Ahmet Yılmaz, Hanwei Cui, Michael A. Caligiuri, Jianhua Yu - Journal of Hematology & Oncology 2020 被引用: 172

  23. CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma

    著者: Jianjun Chu, Youcai Deng, D.M. Benson, Shun He, Tiffany Hughes, Jian Zhang, Yong Peng, Hongyi Mao, Ling Yi, Kalpana Ghoshal, Xiaoming He, Steven M. Devine, Xiaoliu Zhang, Michael A. Caligiuri, Craig C. Hofmeister, Jianhua Yu - Leukemia 2013 被引用: 439

  24. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.

    著者: Wenjuan Dong, Heather Mead, Lei Tian, Jun‐Gyu Park, Juan Ignacio García, Sierra A. Jaramillo, Tasha Barr, Daniel S. Kollath, Vanessa K. Coyne, Nathan E. Stone, Ashley Jones, Jianying Zhang, Aimin Li, Li‐Shu Wang, Martha Milanes‐Yearsley, Jordi B. Torrelles, Luis Martínez‐Sobrido, Paul Keim, Bridget M. Barker, Michael A. Caligiuri, Jianhua Yu - Journal of Virology 2021 被引用: 186